Affiliation:
1. Department of Endocrinology (S.V.R., S.M.S., P.J.T.), Christie Hospital, Manchester M20 4BX, United Kingdom
2. Spanish Group for the Study of Methodology in Clinical Research (L.P.), 28108 Madrid, Spain
3. Health Outcomes Research Europe Group (X.B.), 08201 Barcelona, Spain
4. Hospital Sant Pau (S.M.W.), Autonomous University of Barcelona, E-08025 Barcelona, Spain
Abstract
Acromegaly Quality of Life Questionnaire (AcroQoL) is a new disease-generated quality of life (QOL) questionnaire comprising 22 questions covering physical and psychological aspects of acromegaly and subdivided into “appearance” and “personal relations” categories. We have performed a cross-sectional study of QOL in 80 patients [43 male (mean age, 54.2 yr; range, 20–84); median GH, 0.93ng/ml (range, <0.3 to 23.7); IGF-I, 333.1 ng/ml (range, 47.7–899)] with acromegaly. In addition to AcroQoL, patients completed three generic QOL questionnaires: Psychological General Well-Being Schedule (PGWBS), EuroQol, and a signs and symptoms score (SSS). All three generic questionnaires confirmed impairment in QOL [mean scores: PGWBS, 69.6; EuroQol, visual analog scale, 66.4 (range, 20–100) and utility index, 0.7 (range, −0.07 to 0.92); and SSS, 12 (range, 0–27)]. There was no correlation between biochemical control and any measure of QOL. AcroQoL (57.3%; range, 18.2–93.2) correlated with PGWBS (r = 0.73; P < 0.0001); and in patients with active disease, AcroQoL-physical dimension correlated with SSS (r = −0.67; P < 0.0003). In all questionnaires, prior radiotherapy was associated with impaired QOL. In conclusion, these data underline the marked impact that acromegaly has on patients’ QOL and provide the first evidence validating AcroQoL against well-authenticated measures of QOL. This indicates the potential of AcroQoL as a patient-friendly measure of disease activity.
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference25 articles.
1. A giant’s step forward.;Trainer;Clin Endocrinol (Oxf),2002
2. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly.;Beauregard;Clin Endocrinol (Oxf),2003
3. Factors influencing mortality in acromegaly.;Holdaway;J Clin Endocrinol Metab,2004
4. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.;Serri;J Clin Endocrinol Metab,2004
5. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.;Swearingen;J Clin Endocrinol Metab,1998
Cited by
172 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献